Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study
Neumair, P., Joos, L., Warschkow, R., Dutly, A., Ess, S., Hitz, F., Früh, M., Brutsche, M., Baty, F., Krähenbühl, S., Cerny, T., Joerger, M.Volume:
100
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2016.07.027
Date:
October, 2016
File:
PDF, 1.60 MB
english, 2016